rs770116247

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 5P and 6B. PM1PM5PP2BP4BP6BS2

The NM_000166.6(GJB1):​c.565G>A​(p.Val189Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000133 in 1,204,597 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V189G) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 21)
Exomes 𝑓: 0.000012 ( 0 hom. 8 hem. )

Consequence

GJB1
NM_000166.6 missense

Scores

1
5
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 1.86

Publications

4 publications found
Variant links:
Genes affected
GJB1 (HGNC:4283): (gap junction protein beta 1) This gene encodes a member of the gap junction protein family. The gap junction proteins are membrane-spanning proteins that assemble to form gap junction channels that facilitate the transfer of ions and small molecules between cells. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene cause X-linked Charcot-Marie-Tooth disease, an inherited peripheral neuropathy. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2008]
GJB1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease X-linked dominant 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)
  • X-linked progressive cerebellar ataxia
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM1
In a hotspot region, there are 13 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 17 uncertain in NM_000166.6
PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-71224273-T-G is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 420023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 135 curated pathogenic missense variants (we use a threshold of 10). The gene has 4 curated benign missense variants. Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to Charcot-Marie-Tooth disease X-linked dominant 1, X-linked progressive cerebellar ataxia.
BP4
Computational evidence support a benign effect (MetaRNN=0.3775502).
BP6
Variant X-71224272-G-A is Benign according to our data. Variant chrX-71224272-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 477602.
BS2
High Hemizygotes in GnomAdExome4 at 8 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GJB1NM_000166.6 linkc.565G>A p.Val189Ile missense_variant Exon 2 of 2 ENST00000361726.7 NP_000157.1
GJB1NM_001097642.3 linkc.565G>A p.Val189Ile missense_variant Exon 2 of 2 NP_001091111.1
GJB1NM_001440770.1 linkc.565G>A p.Val189Ile missense_variant Exon 3 of 3 NP_001427699.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GJB1ENST00000361726.7 linkc.565G>A p.Val189Ile missense_variant Exon 2 of 2 1 NM_000166.6 ENSP00000354900.6

Frequencies

GnomAD3 genomes
AF:
0.0000274
AC:
3
AN:
109468
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.0000668
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000190
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000111
AC:
2
AN:
180704
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.0000762
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000122
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000119
AC:
13
AN:
1095129
Hom.:
0
Cov.:
32
AF XY:
0.0000221
AC XY:
8
AN XY:
361835
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26400
American (AMR)
AF:
0.0000284
AC:
1
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.0000924
AC:
5
AN:
54097
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37691
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.00000594
AC:
5
AN:
841950
Other (OTH)
AF:
0.00
AC:
0
AN:
46068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000274
AC:
3
AN:
109468
Hom.:
0
Cov.:
21
AF XY:
0.0000315
AC XY:
1
AN XY:
31776
show subpopulations
African (AFR)
AF:
0.0000668
AC:
2
AN:
29949
American (AMR)
AF:
0.00
AC:
0
AN:
10251
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2617
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3471
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2486
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5815
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
234
European-Non Finnish (NFE)
AF:
0.0000190
AC:
1
AN:
52523
Other (OTH)
AF:
0.00
AC:
0
AN:
1459
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease Uncertain:2
-
Inherited Neuropathy Consortium
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Sep 16, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Dec 06, 2019
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.V189I variant (also known as c.565G>A), located in coding exon 1 of the GJB1 gene, results from a G to A substitution at nucleotide position 565. The valine at codon 189 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species, and isoleucine is the reference amino acid in other vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Dec 02, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 9361298, 36755623) -

Charcot-Marie-Tooth disease X-linked dominant 1 Uncertain:1
Apr 12, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth Neuropathy X Benign:1
Oct 08, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
0.010
T
BayesDel_noAF
Uncertain
-0.030
CADD
Benign
15
DANN
Benign
0.46
DEOGEN2
Uncertain
0.61
D;D;D;D;D
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.84
.;.;.;.;T
M_CAP
Pathogenic
0.45
D
MetaRNN
Benign
0.38
T;T;T;T;T
MetaSVM
Benign
-0.54
T
MutationAssessor
Benign
-0.41
N;N;N;N;N
PhyloP100
1.9
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-0.17
N;.;N;.;N
REVEL
Uncertain
0.51
Sift
Benign
1.0
T;.;T;.;T
Sift4G
Benign
1.0
T;.;T;.;T
Polyphen
0.037
B;B;B;B;B
Vest4
0.63
MutPred
0.55
Loss of catalytic residue at V189 (P = 0.0099);Loss of catalytic residue at V189 (P = 0.0099);Loss of catalytic residue at V189 (P = 0.0099);Loss of catalytic residue at V189 (P = 0.0099);Loss of catalytic residue at V189 (P = 0.0099);
MVP
0.98
MPC
0.63
ClinPred
0.021
T
GERP RS
3.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.072
gMVP
0.89
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770116247; hg19: chrX-70444122; COSMIC: COSV62139661; COSMIC: COSV62139661; API